Land: Ástralía
Tungumál: enska
Heimild: APVMA (Australian Pesticides and Veterinary Medicines Authority)
MELOXICAM
JUROX PTY LIMITED
meloxicam(5mg/mL)
PARENTERAL LIQUID/SOLUTION/SUSPENSION
MELOXICAM UNGROUPED Active 5.0 mg/ml
10mL; 20mL
VM - Veterinary Medicine
CAT | DOG | BITCH | CASTRATE | CAT - QUEEN | CAT - TOM | KITTEN | PUPPY
MUSCULOSKELETAL SYSTEM
MUSCULOSKELETAL CONDITIONS | PAIN/INFLAMMATION ASSOCIATED WITH NONINF | POST SURGICAL PAIN | ARTHRITIS | ARTHROSIS | BURSITIS | EXTERNAL MYOPATHY | INFLAMATION OF SOFT TISSUES AN | OSTEITIS | OSTEOARTHRITIS | TENDON AND LIGAMENT SPRAINS | TENDONITIS | TENOSYNOVITIS | TRAUMATIC JOINT AND CONNECTIVE
Poison schedule: 4; Withholding period: WHP: N/A; Host/pest details: CAT: [PAIN/INFLAMMATION ASSOCIATED WITH NONINF, POST SURGICAL PAIN]; DOG: [MUSCULOSKELETAL CONDITIONS, PAIN/INFLAMMATION ASSOCIATED WITH NONINF, POST SURGICAL PAIN]; Poison schedule: 4; Withholding period: ; Host/pest details: CAT: [PAIN/INFLAMMATION ASSOCIATED WITH NONINF, POST SURGICAL PAIN]; DOG: [MUSCULOSKELETAL CONDITIONS, PAIN/INFLAMMATION ASSOCIATED WITH NONINF, POST SURGICAL PAIN]; An anti-inflammatory injection for dogs and cats.This product is contraindicated for use in pregnant or lactating animals as no data has been established. This product is contraindicated for use in animals less than 6 weeks of age. This product is contraindicated for use in animals suffering from GI..
Registered
2023-07-01
Reliven Injection labeling MAY12 page 1/6 Vial label PRESCRIPTION ANIMAL REMEDY KEEP OUT OF REACH OF CHILDREN FOR ANIMAL TREATMENT -ONLY REL1VEN INJECTION MELOXICAM 5 mg/mL RLP Approved AN ANTI-INFLAMMATORY INJECTION FOR DOGS AND CATS [10 mL][20 mL] [Jurox logo] READ THE ENCLOSED LEAFLET BEFORE USING THIS PRODUCT. DIRECTIONS FOR USE: THIS PRODUCT IS CONTRAINDICATED FOR USE IN PREGNANT OR LACTATING ANIMALS AS NO DATA HAS BEEN ESTABLISHED. THIS PRODUCT IS CONTRAINDICATED FOR USE IN ANIMALS LESS THAN 6 WEEKS OF AGE. DISCARD UNUSED PRODUCT 28 DAYS AFTER FIRST BROACHING VIAL. DOGS: 0.4 mU10 kg single IV or SC. CATS: 0.3 mL/5 kg single SC. Store below 30°C (Room Temperature). APVMA 65707/51670 B. EXP. Jurox Pty Limited Infopest Verified Reliven Injection labeling MAYI2 page 2/6 CARTON FRONT PANEL PRESCRIPTION ANIMAL REMEDY KEEP OUT OF REACH OF CHILDREN FOR ANIMAL TREATMENT ONLY RELIVEN INJECTION Active constituent: MELOXICAM 5 mg/mL AN ANTI-INFLAMMATORY INJECTION FOR DOGS AND CATS [10 mL]j20 mL] [Jurox logo] CARTON: SUBSIDIARY PANELS For the alleviation of inflammation and pain in both acute and chronic musculoskeletal disorders and reduction of postoperative pain and inflammation following orthopaedic and soft tissue surgery in dogs. For the reduction of pain after surgery and management of febrile conditions with appropriate antibiotics in cats. READ THE ENCLOSED LEAFLET BEFORE USING THIS PRODUCT. DIRECTIONS FOR USE: DISCARD UNUSED PRODUCT 28 DAYS AFTER FIRST BROACHING VIAL. CONTRAINDICATIONS: THIS PRODUCT IS CONTRAINDICATED FOR USE IN PREGNANT OR LACTATING ANIMALS AS NO DATA HAS BEEN ESTABLISHED. THIS PRODUCT IS CONTRAINDICATED FOR USE IN ANIMALS LESS THAN 6 WEEKS OF AGE. THIS PRODUCT IS CONTRAINDICATED FOR USE IN ANIMALS SUFFERING FROM GASTROINTESTINAL DISORDERS SUCH AS IRRITATION AND HAEMORRHAGE, IMPAIRED HEPATIC, CARDIAC OR RENAL FUNCTION AND HAEMORRHAGIC DISORDERS, OR WHERE THERE IS EVIDENCE OF INDIVIDUAL HYPERSENSITIVITY TO THE PRODUCT. DOGS Musculoskeletal disorders: a single subcutaneous injection at a dosag Lestu allt skjalið
RELIVEN INJECTION Page 1 of 6 continued ISSUED: 18 MARCH 2013 SAFETY DATA SHEET SECTION 1: IDENTIFICATION OF CHEMICAL PRODUCT AND COMPANY PRODUCT NAME: RELIVEN INJECTION PRODUCT CODE: 504210 (20 mL) RECOMMENDED USE: An anti-inflammatory injection for dogs and cats. COMPANY IDENTIFICATION: Jurox Pty Limited ADDRESS: 85 Gardiner Street Rutherford NSW 2320 Australia CUSTOMER CENTRE: 1800 023 312 NATIONAL POISONS INFORMATION CENTRE: 131126 (Australia-wide) EMERGENCY TELEPHONE NUMBER: 1800 023 312 (9a.m. – 5p.m.) SECTION 2: HAZARDS IDENTIFICATION GHS HAZARD CLASSIFICATIONS: EYE IRRITATION CATEGORY 2A FLAMMABLE LIQUID CATEGORY 3 SKIN CORROSION/IRRITATION CATEGORY 2 GHS PICTOGRAMS*: FLAME EXCLAMATION MARK SIGNAL WORD*: WARNING HAZARD STATEMENTS*: H226 Flammable liquid and vapour. H315 Causes skin irritation. H319 Causes serious eye irritation. PRECAUTIONARY STATEMENTS*: PREVENTION P201 Obtain special instructions before use P202 Do not handle until label safety directions have been read and understood P210 Keep away from open flames - No smoking. P233 Keep container tightly closed. P240 Ground container and receiving equipment. (Production batches only. Not applicable to individual 10 or 20 mL vials) P241 Use explosion-proof equipment. (Production batches only. Not applicable to individual 10 or 20 mL vials) P242 Use only non-sparking tools. (Production batches only. Not applicable to individual 10 or 20 mL vials) P243 Take precautionary measures against static discharge. P264 Wash hands thoroughly after handling. P280 Wear protective gloves and eye protection. RELIVEN INJECTION Page 2 of 6 continued RESPONSE P302+P352 IF ON SKIN: Wash with plenty of soap and water. P303+P361 IF ON SKIN (or hair): Remove immediately all +P353 contaminated clothing. Rinse skin with water. P305+P351 IF IN EYES: Rinse cautiously with water for several minutes. +P338 Remove contact lenses, if present and easy to do. Continue rinsing. P332+P313 If skin irritation occurs: Get medical advice. P337+P313 If eye irritation persists: Get medical Lestu allt skjalið
WWW.JUROX.COM.AU Customer Service 1800 023 312 ® Registered Trademark of Jurox Pty Ltd TECHNICAL NOTES RELIVEN ® Injection ACTIVE CONSTITUENTS Meloxicam 5 mg/mL ACTIONS Meloxicam is a non-steroidal anti-inflammatory drug (NSAID) of the oxicam class which acts by inhibition of prostaglandin synthesis, thereby exerting anti-inflammatory, anti-exudative, analgesic and antipyretic effects. It reduces leukocyte infiltration into the inflamed tissue. INDICATIONS DOGS: For alleviation of inflammation and pain in both acute and chronic musculoskeletal disorders. For reduction of post-operative pain and inflammation following orthopaedic and soft tissue surgery in dogs. CATS: For reduction of pain after surgery. For management of febrile conditions in combination with appropriate antibiotics. CONTRAINDICATIONS This product is contraindicated for use in pregnant or lactating animals as no data has been established. This product is contraindicated for use in animals less than 6 weeks of age. This product is contraindicated for use in animals suffering from gastrointestinal disorders such as irritation and haemorrhage, impaired hepatic, cardiac or renal function and haemorrhagic disorders, or where there is evidence of individual hypersensitivity to the product. As for all NSAIDS, use in any animal less than 6 weeks of age or in debilitated aged animals may involve additional risk. If use in such animals cannot be avoided careful clinical management may be required. WWW.JUROX.COM.AU Customer Service 1800 023 312 ® Registered Trademark of Jurox Pty Ltd TECHNICAL NOTES PRECAUTIONS CATS: Reliven® Injection should be used as a single dose of 0.3 mg meloxicam / kg bodyweight. Safety trials have demonstrated that meloxicam when administered subcutaneously at 0.3 mg/kg at 24 hour intervals for 3 consecutive days in cats, resulted in no side effects in trial animals. Other NSAIDs, diuretics, anticoagulants, aminoglycoside antibiotics and substances with high protein binding may compete for binding and thus lead to toxic effects. Lestu allt skjalið